{"id":"etidronate","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Achalasia of esophagus","Anemia","Aseptic necrosis of bone of jaw","Asthma","Blood coagulation disorder","Duodenitis","Dysphagia","Enterocolitis","Esophageal dysmotility","Esophagitis","Fracture of bone","Gastritis","Heart failure","Hyperphosphatemia","Hypocalcemia","Infectious disease","Invasive Dental Procedure","Kidney disease","Peptic ulcer","Periodontitis","Primary malignant neoplasm","Stricture of esophagus","Swallowing painful","Ulcer of esophagus","Vitamin D deficiency"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201042","moleculeType":"Small molecule","molecularWeight":"249.99"},"aliases":["DIDRONEL®","Etidronate disodium","Didronel"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Type IV secretion-like conjugative transfer relaxase protein TraI"},"_scrapedAt":"2026-03-28T01:11:43.660Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Heterotopic ossification","diseaseId":"heterotopic-ossification","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Humoral hypercalcemia of malignancy","diseaseId":"humoral-hypercalcemia-of-malignancy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Osteitis deformans","diseaseId":"osteitis-deformans","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05662111","phase":"PHASE2","title":"Treatment of Ectopic Calcification in Fahr's Disease or Syndrome","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2023-04-03","conditions":"Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification","enrollment":98},{"nctId":"NCT07353008","phase":"NA","title":"Effect of Different Chelation Protocols on the Healing of Periapical Lesions in Teeth With Chronic Apical Periodontitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mustafa Kemal University","startDate":"2025-12-01","conditions":"Chronic Apical Periodontitis","enrollment":63},{"nctId":"NCT07241650","phase":"NA","title":"Evaluation of the Effects of Different Irrigation Solutions and Activation Methods on Postoperative Pain and Quality of Life in Root Canal Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2025-11-01","conditions":"Irreversible Acute Pulpitis, Root Canal Treatment","enrollment":90},{"nctId":"NCT07116252","phase":"NA","title":"Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez Canal University","startDate":"2023-08-20","conditions":"Irrigation Solution, Postoperative Pain, Inflammation","enrollment":75},{"nctId":"NCT06597825","phase":"NA","title":"Antibacterial Effect of NaOCl With Etidronic Acid in Apical Periodontitis Treatment","status":"COMPLETED","sponsor":"Mustafa Kemal University","startDate":"2020-08-17","conditions":"Healthy","enrollment":40},{"nctId":"NCT06386991","phase":"PHASE4","title":"Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing","status":"RECRUITING","sponsor":"TC Erciyes University","startDate":"2024-01-01","conditions":"Endodontic Disease","enrollment":39},{"nctId":"NCT05778227","phase":"NA","title":"Comparing Different Single and Combination Chelating Agents on Sealer Penetration and Dentin Erosion.","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-11-16","conditions":"Root Canal Infection, Periapical Abscess, Irreversible Pulpitis","enrollment":100},{"nctId":"NCT05832580","phase":"PHASE3","title":"The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2023-04-26","conditions":"Pseudoxanthoma Elasticum","enrollment":76},{"nctId":"NCT01875458","phase":"","title":"Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2012-04-13","conditions":"Osteoporosis, With or Without Treatment, Bisphosphonate Treatment, Atypical Femur Fracture","enrollment":314},{"nctId":"NCT01585402","phase":"PHASE2","title":"Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2012-08-20","conditions":"Arterial Calcification, CD73 Deficiency","enrollment":7},{"nctId":"NCT01077817","phase":"","title":"Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-02-26","conditions":"Esophageal Cancer, Squamous Cell Carcinoma, Adenocarcinoma","enrollment":684815},{"nctId":"NCT02614404","phase":"PHASE1","title":"Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"HuLow","startDate":"2015-11","conditions":"Plasmodium Falciparum Malaria","enrollment":15},{"nctId":"NCT03458559","phase":"PHASE3","title":"Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy","status":"UNKNOWN","sponsor":"Amsterdam UMC, location VUmc","startDate":"2018-05-16","conditions":"Prostate Cancer Metastatic to Bone","enrollment":402},{"nctId":"NCT04035330","phase":"NA","title":"Effect of Etidronate in Sodium Hypochlorite Versus Sodium Hypochlorite on the Intensity of Postoperative Pain","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-09","conditions":"Necrotic Pulp","enrollment":34},{"nctId":"NCT02731040","phase":"","title":"Exome Sequencing for Atypical Femoral Fractures","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-04","conditions":"Atypical Femoral Fractures, Osteoporosis, Bisphosphonate Therapy","enrollment":38},{"nctId":"NCT03697668","phase":"PHASE2","title":"Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites","status":"UNKNOWN","sponsor":"Nurex S.r.l.","startDate":"2017-09-17","conditions":"Plasmodium Falciparum Malaria (Drug Resistant)","enrollment":50},{"nctId":"NCT00843466","phase":"NA","title":"Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2007-05","conditions":"Hand Dermatosis","enrollment":46},{"nctId":"NCT02673060","phase":"PHASE1","title":"A Trial of MBC-11 in Patients With CIBD","status":"COMPLETED","sponsor":"Osteros Biomedica Ltd","startDate":"2014-07","conditions":"Bone Metastasis","enrollment":16},{"nctId":"NCT00679978","phase":"","title":"Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid","status":"COMPLETED","sponsor":"Saitama Medical University","startDate":"2001-01","conditions":"Vertebral Fracture, Osteonecrosis, Rheumatic Diseases","enrollment":60},{"nctId":"NCT00376662","phase":"PHASE4","title":"HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.","status":"COMPLETED","sponsor":"British Thoracic Society","startDate":"1992-08","conditions":"Osteoporosis","enrollment":750}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_3","status":"active","brandName":"Etidronate","genericName":"Etidronate","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1977-09-01T00:00:00.000Z","mah":"APIL","brand_name_local":"DIDRONEL","application_number":"NDA017831"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-04-20T00:00:00.000Z","mah":"MGI PHARMA INC","brand_name_local":"DIDRONEL","application_number":"NDA019545"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-01-24T00:00:00.000Z","mah":"PHARMOBEDIENT","brand_name_local":"ETIDRONATE DISODIUM","application_number":"ANDA075800"}],"trialStats":{"total":2,"withResults":2},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}